Discussions actives
CSS, formulaire et labels multilignes (2)CSS, XHTML et formulaire (12)
Espresso : étapes de construction des CSS (7)
Images de fond, boites rondes (13)
Images d'arrière plan (8)
FDA Updates portray for Avandia to embrace Clinical Findings
--> FDA Updates portray for Avandia to embrace Clinical Findings
figures Provides auxiliary dirt on AVANDIA as a OK and outstanding Treatment privilege for befitting strain 2 Diabetes Patients
PHILADELPHIA, July 14, 2008 /PRNewswirs-FirstCall/ -- GlaxoSmithKline announces today that the U.S. viands and stimulant authority (FDA) updated the prescribing low-down for AVANDIA(R) (rosiglitazone maleate) to subsume clinical findings from A Diabetes development broadening stab (accept), a 4- to- 6 year crumpet-to-crumplet examination of AVANDIA versus metformin and glyburide monoremedial lay out in recently diagnosed gradeification 2 diabetes patients. The share of patients with inaverage glucose hold sway over at five years was 34 percent with glyburide, 21 percent with metformin and at most 15 percent with AVANDIA. The reformation between AVANDIA and the comparators was statistically significanr.
PHILADELPHIA, July 14, 2008 /PRNewswirs-FirstCall/ -- GlaxoSmithKline announces today that the U.S. viands and stimulant authority (FDA) updated the prescribing low-down for AVANDIA(R) (rosiglitazone maleate) to subsume clinical findings from A Diabetes development broadening stab (accept), a 4- to- 6 year crumpet-to-crumplet examination of AVANDIA versus metformin and glyburide monoremedial lay out in recently diagnosed gradeification 2 diabetes patients. The share of patients with inaverage glucose hold sway over at five years was 34 percent with glyburide, 21 percent with metformin and at most 15 percent with AVANDIA. The reformation between AVANDIA and the comparators was statistically significanr.
Ecrit par , le Mercredi 23 Juillet 2008, 23:48 dans la rubrique "Premiers Pas".
Version XML
- Cette page est peut-être encore valide XHTML1.1 et CSS sans tableaux.
Thème inspiré par Bryan Bell.
Thème inspiré par Bryan Bell.